This federal contract award is for the procurement of AMICUS cell separators and accessories by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The $110,982.87 firm fixed-price purchase order was awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract has a period of performance ending on September 3, 2025. Fenwal, which is a registered vendor with the U.S. federal government, has a history of providing a wide range of medical supplies and equipment to support transfusion medicine and cell therapy applications for various agencies, including the Department of Defense, Department of Veterans Affairs, and NIAID. This contract award does not have a set-aside designation, reflecting Fenwal's specialized capabilities in the field of apheresis equipment and related consumables.
Generated 9/4/24, 9:28 AM